Alprostadil 10mcg/Papaverine 30mg/Phentolamine 1mg/ml lnj Soln recalled over sterility concerns
- Recall date
- March 26, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy recalls Alprostadil 10mcg/Papaverine 30mg/Phentolamine 1mg/ml lnj Soln, 5 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PH…
- Recall number
- D-1099-2020
- FDA classification
- Class II
- Brand / firm
- Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
- Sold / distributed
- Patient Distribution list includes addresses in the following states: CA, ME, TX
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Alprostadil 10mcg/Papaverine 30mg/Phentolamine 1mg/ml lnj Soln, 5 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562 951-304-9530
Get recall alerts
Free email alert whenever Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy